Pressure BioSciences Inc. PBIO Archives

WednesdaySep 28, 2022 11:55 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Focus on Launch of Proprietary UST Processing Method in Emerging Growth Conference Presentation

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries, is presenting at today’s Emerging Growth Investor Conference. The conference has built a reputation for being an effective way for publicly traded companies to present and communicate new products and services as well as other major announcements to thousands of individual and institutional investors and investment advisors and analysts. PBI president and CEO Richard T. Schumacher spoke at 9 a.m. ET; the focus of…

TuesdaySep 27, 2022 3:54 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Ultra Shear Technology(TM) Platform Showcased at the Conference of Food Engineering 2022

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide food and beverage, health and wellness, nutraceuticals, and other industries. The company today announced two significant presentations given at the Conference of Food Engineering 2022 by a distinguished research team at the College of Food, Agricultural and Environmental Sciences at The Ohio State University and co-authored by members of PBI’s R&D and Engineering teams. “The results of these studies presented by our colleagues at OSU provides strong and invaluable support to our impending commercial…

TuesdaySep 13, 2022 2:49 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation at H. C. Wainwright Annual Global Investment Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries. The company today announced its participation in the H. C. Wainwright Annual Global Investor Conference taking place from Sept. 12-14, 2022. This conference features a number of exciting, rapidly growing public and private companies, presenting for 30 minutes each. During PBI’s presentation, which took place live beginning at 1:30 p.m. ET on Sept. 13, the company’s President and CEO Richard T. Schumacher…

WednesdayAug 24, 2022 11:07 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Partners with Skincare Leader, Icon and Pioneer

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmetics, agrochem and food/beverage industries, has signed a two-year collaborative research and development agreement with Dr. Adrienne Denese, MD, PhD. Creator of the award-winning SkinScience Labs, Denese is a recognized QVC icon, industry Visionary, anti-aging pioneer and founder and president of Dr. Denese SkinScience, one of the most successful, highly rated, and longest-lasting skincare lines in the history of QVC. According to the agreement, PBI and Dr. Denese SkinScience will work together to develop skincare…

ThursdayAug 18, 2022 12:07 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Strategic Agreement with Canopy CBD Farms

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide nutraceuticals, biotechnology, cosmetics, and food and beverage industries. The company today announced the execution of a manufacturing, sales and distribution agreement with Canopy CBD Farms LLC (“CCF”), a Massachusetts licensed processor/manufacturer/distributor of hemp-derived CBD products and processing equipment. With a strong focus in the Massachusetts/New England hemp-derived CBD market and with hundreds of nationwide industry connections, CCF has assembled an aggressive distribution plan that anticipates nano-CBD product sales of nearly $6 million over the…

ThursdayAug 11, 2022 12:33 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Approval to Manufacture Hemp-Derived CBD Products in South Easton Facility

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biopharmaceuticals and other industries. The company today announced approval for its South Easton, Massachusetts, facility to manufacture custom, compliant, hemp-derived CBD nanoemulsions under the processing/manufacturing license of its commercial partner, Canopy CBD Farms (“CCF”). CFF is a Massachusetts-licensed hemp processing and manufacturing company. “I am delighted to partner with PBI by extending my CBD processing and manufacturing license to PBI’s South Easton location,” said John Westlake, founder and president of CCF. “I firmly believe…

FridayAug 05, 2022 12:42 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Gathers Leads at Events, Notes Rapid Market Expansion

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmetics, agrochem, and food/beverage industries, is reporting more than 60 strong leads gathered from its participation at two cannabis drink expo events, one in San Francisco and one in Chicago. The positive response is indicative of the rapid market expansion and potential for cannabis beverages, the company observes. Company officials also noted that a common theme at both events was the need for faster, more effective delivery of cannabis dosing with reliably repeatable precision.…

ThursdayJul 21, 2022 1:00 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide nutraceuticals, biotherapeutics and other industries. The company today announced its entry into an agreement with North Star Holdings (“NSH”) on the financial partnership for the development, production, distribution and commercial roll-out of NSH’s novel, effectively water-soluble, nanoemulsified CBD spray for topical use. In addition, PBI will partner with the NSH team on the development and distribution of additional nano-CBD containing products that the highly successful Colorado cannabis operator has already suggested. “John's years of…

WednesdayJul 06, 2022 12:14 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Emerging Growth Conference

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries, will be presenting at the July 6, 2022, Emerging Growth Investor Conference. This elite event features rapidly growing public companies; each company presents a 30–45-minute overview to those in attendance. PBIO president and CEO Mr. Richard T. Schumacher will represent Pressure BioSciences at the event; his presentation, which will include a Q&A session, is slated to begin at 10:30 a.m. ET. The presentation will…

TuesdayJul 05, 2022 12:26 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at 34th Emerging Growth Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, is presenting in the 34th Emerging Growth Conference. At the event, slated to take place on July 6, 2022, PBI’s president and CEO Richard T. Schumacher will deliver a keynote speech starting at 10:30 a.m. ET. Interested parties should visit https://ibn.fm/zI2PU to register for the event, after which attendees will receive an email containing the link and time to sign into the conference. Questions for presenting companies may be submitted in advance to Questions@EmergingGrowth.com…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO